1,530 results on '"Capasso, Giovambattista"'
Search Results
2. Bone mineral density assessment in patients with cystinuria
3. Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
4. Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease
5. Single nephron glomerular filtration rate measured by linescan multiphoton microscopy compared to conventional micropuncture
6. #883 P-cresyl sulphate and Indoxyl sulphate: two uremic toxins stimulating colon cancer progression in patients with chronic renal failure
7. #3042 Prevalence and associations of impaired cognitive function for people with chronic kidney disease: baseline findings from the NURTuRE-CKD cohort study
8. #2490 Analyzing the morphology of mesothelial cells when exposed to peritoneal dialysis solutions
9. #2665 Acute kidney injury (AKI) and chronic kidney disease (CKD) in living kidney donors (LKD): time for a new “surgical” classification system?
10. Renal cystinuria and immune cells (T lymphocytes) dysfunction, what we know about?
11. Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells
12. Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.
13. Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation
14. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders
15. Urinary proteomics reveals key markers of salt sensitivity in hypertensive patients during saline infusion
16. Animal models to study cognitive impairment of chronic kidney disease.
17. Cognitive decline related to chronic kidney disease as an exclusion factor from kidney transplantation: results from an international survey.
18. Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl Syndrome
19. How to assess kidney function in oncology patients
20. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations
21. Bone mineral density assessment in patients with cystinuria
22. The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI
23. Legislative proposal in Italy to facilitate contacts between deceased organ donor families and transplant recipients
24. Evaluation of endogenous miRNA reference genes across different zebrafish strains, developmental stages and kidney disease models
25. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
26. Diffusion tensor imaging for the study of early renal dysfunction in patients affected by bardet-biedl syndrome
27. Urinary extracellular vesicles: single patient analysis for clinical applications
28. Mechanisms of cognitive dysfunction in CKD
29. Animal models to study cognitive impairment of chronic kidney disease
30. Renal Function Outcomes at 5 Years from Radical and Partial Nephrectomies in Normal Renal Function Patients: An Insidious Tale of Failed Renal Hyperfiltrations: PUB321
31. Renal Surgery and Postoperative AKI Risk in Normal Renal Function Patients: A Hidden Threat: PUB063
32. Neuropeptide Y gene polymorphisms and chronic kidney disease progression.
33. Cyclosporin-induced hypertension is associated with the up-regulation of Na+-K+-2Cl− cotransporter (NKCC2).
34. Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations.
35. Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease
36. Cyclosporin-induced hypertension is associated with the up-regulation of Na+-K+-2Cl− cotransporter (NKCC2)
37. The human EV membranome
38. Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin
39. A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice
40. Urinary proteome in inherited nephrolithiasis
41. Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation
42. Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure
43. #4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS
44. #6839 MULTIDISCIPLINARY APPROACH TO STUDY THE BIOLOGICAL FUNCTION OF BBS10 IN THE PATHOGENESIS OF BARDET-BIEDL SYNDROME (BBS)
45. Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed
46. Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway
47. Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
48. Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
49. The Probe for Renal Organic Cation Secretion (4-Dimethylaminostyryl)-N-Methylpyridinium (ASP+)) Shows Amplified Fluorescence by Binding to Albumin and Is Accumulated In Vivo.
50. The Physiology of the Loop of Henle
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.